中图分类号R969.3 文献标志码A 文章编号 1001-0408(2025)09-1025-05

    DOI 10.6039/j.issn.1001-0408.2025.09.01

    ABSTRACT OBJECTIVE To assess the scientific rigor， clarityandfeasibilityoftherecommendationsofthe GuidelinesforEvidence-basedUseofBiological Agentsforthe Clinical TreatmentofOsteoporosis(hereinafterreferredtoas theGuideline)through external review，in order to further revise andimprovetheGuidelinerecommendations. METHODS This study employed a cross-sectional survey research design，a convenience sampling method was adopted

    toselectfrontlinemedicalworkersinthefieldfosteoporosis(includingclnicaldoctors，iicalpharmacistsandurses)aswel aspatientsortheirfamilymembers.Externalreviewwasconductedthroughacombinationofclosed-endedandopen-ended electronicquestionnairestogetfeedbackfromthemontheappreciation，clarityandfeasibilityofthe32preliminary recommendationsintheGuideline.RESULTSAtotalof90externalreviewsubjetsfrom15hospitalswerecollected，including45 clinicaldoctors，15clinicalpharmacists，15nursesand15patientsortheirfamilymembers.Theoverallappreciationdegreeof recommendations was 9 9 . 3 8 % ......